GLP1R and type 2 diabetes mellitus: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) represent a relatively recent class of antidiabetic agents that have significantly enhanced glycemic control in patients with T2D, while also providing cardiovascular benefits and promoting weight loss [185].